Technical Analysis for AMRN - Amarin Corporation plc

Grade Last Price % Change Price Change
F 0.84 -2.55% -0.02
AMRN closed down 2.55 percent on Monday, March 18, 2024, on 45 percent of normal volume. The stock exhibited some range contraction during this trading session as price made an NR7 -- narrowest range of the last seven sessions. Due to the stock's strong downtrend, it may remain oversold for a while. So, if you're looking for a reason to buy, don't put too much weight on it being oversold.
2 Watchers
Watchlist Portfolio

Trend Table & Recent EOD Trading Signals

ADX Long Term Intermediate Term Short Term
Strong Down Down Down

Date Alert Name Type % Chg
Boomer Sell Setup Bearish Swing Setup 0.00%
NR7 Range Contraction 0.00%
Inside Day Range Contraction 0.00%
Wide Bands Range Expansion 0.00%
Oversold Stochastic Weakness 0.00%
Inside Day Range Contraction -2.55%
Wide Bands Range Expansion -2.55%
Oversold Stochastic Weakness -2.55%
Reversal New Lows Setup Bearish Swing Setup 1.84%
Outside Day Range Expansion 1.84%

   Recent Intraday Alerts

Alert Time
Possible NR7 about 12 hours ago
Possible Inside Day about 12 hours ago
60 Minute Opening Range Breakdown about 15 hours ago
Down 3% about 15 hours ago
Down 2 % about 16 hours ago

Get a Trading Sidekick!

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.

Profile

Amarin Corporation plc Description

Amarin Corporation plc, a biopharmaceutical company, focuses on the development and commercialization therapeutic products for the treatment for cardiovascular diseases. Its product development program areas include lipid science and therapeutic benefits of polyunsaturated fatty acids. The company lead product comprises Vascepa, a prescription-only omega-3 fatty acid comprising icosapent ethyl as an adjunct to diet to reduce triglyceride levels in adult patients with severe hypertriglyceridemia. It also engages in developing Vascepa for the treatment of patients with high triglyceride levels who are also on statin therapy for elevated low-density lipoprotein cholesterol levels. The company was formerly known as Ethical Holdings plc. Amarin Corporation plc was founded in 1989 and is headquartered in Dublin, Ireland.


Classification

Sector: Healthcare
Industry: Biotechnology
Keywords: Biopharmaceutical Acid Organic Compounds Cardiovascular Disease Therapeutic Products Lipid Vascular Disease Nutrition Cholesterol Fatty Acids Lipoprotein Low Density Lipoprotein Triglyceride Hypertriglyceridemia Polyunsaturated Fat Saturated Fat Statin Therapy

Is AMRN a Buy, Sell or Hold?

Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength

Indicators

Indicator Value
52 Week High 1.6575
52 Week Low 0.651
Average Volume 2,395,807
200-Day Moving Average 1.01
50-Day Moving Average 1.11
20-Day Moving Average 1.03
10-Day Moving Average 0.89
Average True Range 0.07
RSI (14) 33.77
ADX 30.51
+DI 10.49
-DI 28.88
Chandelier Exit (Long, 3 ATRs) 1.14
Chandelier Exit (Short, 3 ATRs) 1.02
Upper Bollinger Bands 1.36
Lower Bollinger Band 0.70
Percent B (%b) 0.21
BandWidth 64.23
MACD Line -0.08
MACD Signal Line -0.06
MACD Histogram -0.0225
Fundamentals Value
Market Cap 341.74 Million
Num Shares 408 Million
EPS -0.12
Price-to-Earnings (P/E) Ratio -6.98
Price-to-Sales 1.54
Price-to-Book 0.89
PEG Ratio -1.74
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 0.89
Resistance 3 (R3) 0.90 0.88 0.88
Resistance 2 (R2) 0.88 0.86 0.88 0.88
Resistance 1 (R1) 0.86 0.85 0.85 0.86 0.88
Pivot Point 0.84 0.84 0.84 0.84 0.84
Support 1 (S1) 0.82 0.83 0.81 0.82 0.80
Support 2 (S2) 0.80 0.82 0.80 0.79
Support 3 (S3) 0.78 0.80 0.79
Support 4 (S4) 0.78